A Cost-Effectiveness Analysis of Adjuvant Chemoradiotherapy for Resected Gastric Cancer

BACKGROUND: The Intergroup 0116 trial demonstrated that adding postoperative chemoradiotherapy for gastric cancer resulted in a significant overall survival improvement of 9 months. The purpose of this study was to perform a cost-effectiveness analysis of adjuvant chemoradiotherapy for resected gast...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wang, Samuel J., Fuller, Clifton D., Choi, Mehee, Thomas, Charles R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: International Society of Gastrointestinal Oncology 2008
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630819/
https://ncbi.nlm.nih.gov/pubmed/19259297
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller